![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Synthon B.v. Nijmegen Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Risperidone, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2004-126 - Rev 00
This Chemical Type CEP, issued on October 04, 2006, remains in force until April 15, 2011, ensuring its reliability within the pharmaceutical industry.
Substance Number 1559 associated with this CEP further emphasizes